NDC 43066-993
Clindamycin phosphate 600 mg per 50 mL injection, solution
On the label: Baxter Healthcare Corporation.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation | Round Lake, IL, United States | Makes it, tests it, packages it, labels it and sterilizes it | Serious problems, FDA actionApr 2, 2026 · 15 inspections, 2 with FDA action |
Recalls
- Aug 6, 2026 · Class II · Baxter Healthcare Corporation
CGMP Deviations
Lots: Lot # NC194068, Exp Date: 10/29/2027.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 600 mg per 50 mL
- Approval
- ANDA ANDA208084
- On the market since
- Jun 28, 2017
- Package NDCs
43066-993-24- Official label
- DailyMed (National Library of Medicine), updated May 15, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?